%0 Journal Article
%A Akbarovna, Bakhtiyarova Dilnura
%D 2026
%F arxiv:65418
%I Center for Tech and Media Research
%J Multidisciplinary Journal of Science and Technology
%K chronic hepatitis B, nucleos(t)ide analogues, antiviral therapy, safety, efficacy, HBV DNA
%T SAFETY AND EFFICACY OF LONG-TERM TREATMENT WITH NUCLEOS(T)IDE ANALOGUES IN CHRONIC HEPATITIS B
%U https://arxiv.universalpublishings.com/id/eprint/65418/
%X Chronic hepatitis B (CHB) remains a major global public health problem, leading to progressive liver disease, cirrhosis, and hepatocellular carcinoma. Long-term antiviral therapy with nucleos(t)ide analogues (NAs) is the cornerstone of CHB management, aiming to suppress hepatitis B virus (HBV) replication, prevent disease progression, and reduce liver-related complications. Despite proven antiviral efficacy, prolonged NA therapy raises concerns regarding drug resistance, safety, renal and bone toxicity, and long-term patient adherence. This study was conducted at the Khorezm Regional Multidisciplinary Medical Center and aimed to evaluate the safety and efficacy of long-term treatment with nucleos(t)ide analogues in patients with chronic hepatitis B. Patients were assessed based on virological, biochemical, and clinical parameters during extended antiviral therapy. The results demonstrate that long-term NA treatment effectively suppresses HBV replication, improves liver function, and is generally well tolerated, confirming the importance of continuous antiviral therapy in the management of chronic hepatitis B.
%Z Imported from MJST Journal (OAI id oai:ojs.pkp.sfu.ca:article/6642)